# Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

> **NCT03236064** · PHASE1 · UNKNOWN · sponsor: **WellSpan Health** · enrollment: 10 (estimated)

## Conditions studied

- Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter

## Interventions

- **DRUG:** Polyethylene Glycols

## Key facts

- **NCT ID:** NCT03236064
- **Lead sponsor:** WellSpan Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2024-05
- **Final completion:** 2024-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03236064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03236064, "Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03236064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*